Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Currently, targeting the NLRP3 inflammasome pathway or directly neutralizing IL-1 (e.g., Canakinumab) is considered a highly promising frontier for treating refractory gout and preventing gout flares [2]
Other GLP-1 Receptor Agonists Dulaglutide: A GLP-1 receptor agonist like semaglutide for blood sugar control and weight management can be a good option for some patients
When can results be expected in studies
448 MilivojevicMCheXBatemanLChengAGarciaBAHornigMet al
The exact concentration depends on the cell type and the research question
US$ 24.92
US$ 27.79
